Hims vs Ro
Hims has an open FDA warning letter dated September 9, 2025. Ro has none. No price lines up like for like. They share brand-name semaglutide pen, but both price it at $199, and in each case that covers the medication only, with a separate membership on top.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Hims / Ro
Hims
6.7/10
Ro
7.4/10
- Apostrophe Pharmacy LLC503A
- XeCare LLC503A
- Strive Specialties, Inc.503A
- and 2 more
- Roman Health Pharmacy LLCtype not stated
Neither Hims nor Ro pays us. Links to them earn nothing. Scores: Hims 6.7, Ro 7.4. How we are paid
What the record shows
- 01
Hims has an open FDA warning letter dated September 9, 2025. Ro has none.
- 02
No price lines up like for like. They share brand-name semaglutide pen, but both price it at $199, and in each case that covers the medication only, with a separate membership on top.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Hims
Ro
$199/mo
medication only, membership extra; not compared
$199/mo
medication only, membership extra; not compared
$299/mo
medication only, membership extra; not compared
$299/mo
medication only, membership extra; not compared
$149/mo
medication only, membership extra; not compared
$149/mo
medication only, membership extra; not compared
$149/mo
medication only, membership extra; not compared
$149/mo
medication only, membership extra; not compared
Read off each seller’s own pages. Hims: October 17, 2026. Ro: October 31, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Hims
6.7/10The record gives Hims no edge on this pair.
- Open FDA warning letter, September 9, 2025
- Price leaves out clinician visits and coaching
- Lowest price covers the medication only, with a separate membership on top
The case for Ro
7.4/10- No FDA warning letter on record
- Price includes clinician visits and coaching
- Price leaves out medication
- Lowest price covers the medication only, with a separate membership on top
Scores
Hims 6.7 · Ro 7.4 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Hims vs Ro: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- HumeCare+6.6
From $199/mo
Visit site - Collective9.1
From $59/mo
Visit site - Embody9.3
From $79/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks